Eevia Health

Eevia Health, a Finnish-Norwegian biotechnology startup founded in 2013, is focused on harnessing the power of Arctic flora to address significant health challenges. The company's emphasis on organic, bioactive ingredients sourced from natural, organic raw materials found in the Arctic flora aligns with the growing demand for natural health solutions. Eevia Health's collaboration with universities and research organizations in Scandinavia enhances its ability to deliver exceptional products, particularly those targeting anti-inflammation and antioxidant benefits. The recent kr7.50M Post-IPO Debt investment at 20 May 2024 by Formue Nord underscores investor confidence in the company's potential. With its emphasis on the role of good health in meeting today's lifestyle demands and the belief that better health contributes to better business, Eevia Health presents a compelling case for investment in the biotechnology sector.